Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: South Med J. 2016 Jan;109(1):24–30. doi: 10.14423/SMJ.0000000000000396

Table 2.

Epidemiologic and quality of care metrics for breast cancer in the US and SC, by race

United States (US) South Carolina (SC) Target
All White Black All White Black
Yearly
Mammography
screening (40+)		 69.0%
(68.5, 69.4)
n=125,841		 68.8%
(68.3,
69.2)
n=106,331		 72.0%
(70.5,
73.5)
n=12,677		 64.8%
(62.8, 66.7)
n=3,496		 64.3%
(62.0,
66.6)
n=2,322		 67.0%
(63.3,
70.8)
n=1,101		 N/A
Biennial
Mammography
screening (40+)		 74.3 %
(73.9, 74.7)
n=158,517		 74.1 %
(73.7,
74.6)
n=133,920		 77.3 %
(76.0,
78.6)
n=15,725		 71.4 %
(69.6, 73.1)
n=4,520		 70.0 %
(67.9,
72.1)
n=3,003		 76.8 %
(73.6,
79.7)
n=1,412		 N/A
Biennial
Mammography
screening (50-
74)		 78.7%
(78.2, 79.2)
n=104,328		 78.3 %
(77.8,
78.8)
n=87,948		 82.2 %
(80.6,
83.6)
n=10,755		 75.7 % (73.6,
77.7)
n=3,022		 73.9 %
(71.3,
76.3)
n=1,596		 81.9 %
(78.3,
85.0)
n=984		 HP2020:
81.1%
Clinical Breast
Exam (CBE) for
women age
40+ in three
years		 65.4%
(64.9, 65.8)
n=124,871		 64.4%
(64.0,
64.9)
n=105,735		 71.9%
(70.5,
73.3)
n=12,419		 60.7%
(58.8, 62.6)
n=3,373		 59.4%
(57.1,
61.6)
n=2,279		 66.0%
(62.3,
69.7)
n=1,022		 SCCA:
75.0%
Late-stage
breast cancer
diagnosis rate		 N/A N/A N/A SCCCR:
N/A		 SCCCR:
35.0%		 SCCCR:
46.5%		 HP2020:
38.9 per
100,000
Image or
palpitation
guided- needle
biopsy		 CoC:
82.9%
(82.7-83.1)
n=1341		 N/A N/A SCCCR:
75.5 %
CoC: 87.8%
(86.5-89.1)		 SCCCR:
76.8 % 		SCCCR:
71.3% 		SCCA:
90.0%
Breast-
conserving surgery (BCS)
and radiation
therapy within 1
year of
diagnosis (Age
<
70)		 CoC:
92.3%
(92.1-92.5)
n=1326		 N/A N/A SCCCR:
71.1%
CoC: 94.8%
(93.3-98.7)		 SCCCR:
73.6%		 SCCCR:
64.6% 		SCCA:
73.5%
Negative breast
cancer and
chemo
administered
within 4 months
of diagnosis
(Age <70)		 CoC:
92.8%
(92.4-93.2)
n=1256		 N/A N/A SCCCR:
76.0%
CoC: 97.4%
(96.3-99.5)		 SCCCR:
76.7% 		SCCCR:
75.3% 		SCCA:
97.2 %
Positive breast
cancer and
tamoxifen/
aromatase
inhibitor within
12 months of
diagnosis (Age
<70)		 CoC:
91.1%
(90.9-91.3)
n=1331		 N/A N/A SCCCR:
55.8%8
CoC: 92.3%
(90.7-93.9)		 SCCCR:
57.0% 		SCCCR:
51.3% 		SCCA:
90.0%
Percentage of
patients who
are treated with
BCS		 CoC:
64.0%
(63.7-64.3)
n=1328		 N/A N/A SCCCR:
62.5%
CoC: 64.8%
(62.8-66.8)		 SCCCR:
63.0%		 SCCCR:
61.0%		 NAPBC:
50.0%
(Reduce) Age-
Adjusted
Invasive Breast
Cancer
Incidence Rate		 124.6 per
100,000		 127.3 per
100,000		 118.4 per
100,000		 123 per
100,000		 124.0 per
100,000		 118.5 per
100,000		 N/A
(Reduce) Age-
Adjusted Breast
Cancer Death
Rates		 22.6 per
100,000		 22.7 per
100,000		 30.8 per
100,000		 24.0 per
100,000		 21.3 per
100,000		 29.8 per
100,000		 HP 2020:
20.7 per
100,000

*Whites and Blacks in these categories include Hispanic populations

*Bolded items signify lower adherence than the target

SCCA: South Carolina Cancer Alliance

HP 2020: Health People 2020

NAPBC: National Accreditation Program for Breast Centers

CoC: Commission on Cancer- accredited cancer programs nationwide

SCCCR: South Carolina Central Cancer Registry